ATE409032T1 - Orodispersible pharmazeutische zusammensetzung einer antithrombotischen verbindung - Google Patents

Orodispersible pharmazeutische zusammensetzung einer antithrombotischen verbindung

Info

Publication number
ATE409032T1
ATE409032T1 AT04767690T AT04767690T ATE409032T1 AT E409032 T1 ATE409032 T1 AT E409032T1 AT 04767690 T AT04767690 T AT 04767690T AT 04767690 T AT04767690 T AT 04767690T AT E409032 T1 ATE409032 T1 AT E409032T1
Authority
AT
Austria
Prior art keywords
antithrbotic
compound
pharmaceutical composition
orodispersible pharmaceutical
orodispersible
Prior art date
Application number
AT04767690T
Other languages
English (en)
Inventor
Patrick Wuthrich
Herve Rolland
Marc Julien
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE409032T1 publication Critical patent/ATE409032T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04767690T 2003-07-18 2004-07-16 Orodispersible pharmazeutische zusammensetzung einer antithrombotischen verbindung ATE409032T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0308780A FR2857593B1 (fr) 2003-07-18 2003-07-18 Composition pharmaceutique orodispersible d'un compose antithrombotique

Publications (1)

Publication Number Publication Date
ATE409032T1 true ATE409032T1 (de) 2008-10-15

Family

ID=33548240

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04767690T ATE409032T1 (de) 2003-07-18 2004-07-16 Orodispersible pharmazeutische zusammensetzung einer antithrombotischen verbindung

Country Status (27)

Country Link
US (1) US20060167100A1 (de)
EP (1) EP1646373B1 (de)
JP (1) JP2006528160A (de)
KR (1) KR100762598B1 (de)
CN (1) CN100544709C (de)
AR (1) AR045724A1 (de)
AT (1) ATE409032T1 (de)
AU (1) AU2004258713B2 (de)
BR (1) BRPI0412706A (de)
CA (1) CA2532608A1 (de)
DE (1) DE602004016751D1 (de)
DK (1) DK1646373T3 (de)
EA (1) EA010372B1 (de)
ES (1) ES2314440T3 (de)
FR (1) FR2857593B1 (de)
GE (1) GEP20094649B (de)
HR (1) HRP20080521T3 (de)
MA (1) MA27891A1 (de)
MX (1) MXPA06000712A (de)
MY (1) MY138799A (de)
NO (1) NO20060803L (de)
PL (1) PL1646373T3 (de)
PT (1) PT1646373E (de)
SI (1) SI1646373T1 (de)
UA (1) UA79567C2 (de)
WO (1) WO2005009428A2 (de)
ZA (1) ZA200600241B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2899473B1 (fr) * 2006-04-07 2008-06-13 Servier Lab Utilisation d'un compose anti-atherothrombotique pour l'obtention de medicaments destines au traitement des troubles vasculaires
US20100084223A1 (en) 2007-05-11 2010-04-08 Fargo Richard N Elevator load bearing assembly having an initial factor of safety based upon a desired life of service
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine
US8307129B2 (en) * 2008-01-14 2012-11-06 International Business Machines Corporation Methods and computer program products for swapping synchronous replication secondaries from a subchannel set other than zero to subchannel set zero using dynamic I/O
US7761610B2 (en) * 2008-01-25 2010-07-20 International Business Machines Corporation Methods and computer program products for defining synchronous replication devices in a subchannel set other than subchannel set zero
US8516173B2 (en) * 2008-07-28 2013-08-20 International Business Machines Corporation Swapping PPRC secondaries from a subchannel set other than zero to subchannel set zero using control block field manipulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US6171616B1 (en) * 1998-04-13 2001-01-09 Shin-Etsu Chemical Co., Ltd. Solid preparation and a method of manufacturing it
EP1175899B1 (de) * 2000-07-27 2007-08-29 Roquette FrÀ¨res Granulat bestehend aus Stärke und Laktose
KR200250082Y1 (ko) * 2001-05-15 2001-11-16 포스텍전자주식회사 힌지 유니트

Also Published As

Publication number Publication date
EA200600173A1 (ru) 2006-08-25
PT1646373E (pt) 2008-11-13
KR20060031688A (ko) 2006-04-12
MA27891A1 (fr) 2006-05-02
PL1646373T3 (pl) 2009-02-27
GEP20094649B (en) 2009-03-25
SI1646373T1 (sl) 2009-02-28
EA010372B1 (ru) 2008-08-29
AU2004258713B2 (en) 2007-07-12
CN100544709C (zh) 2009-09-30
ZA200600241B (en) 2007-04-25
UA79567C2 (en) 2007-06-25
AR045724A1 (es) 2005-11-09
FR2857593B1 (fr) 2005-10-14
ES2314440T3 (es) 2009-03-16
EP1646373B1 (de) 2008-09-24
EP1646373A2 (de) 2006-04-19
MY138799A (en) 2009-07-31
HK1094152A1 (zh) 2007-03-23
DK1646373T3 (da) 2008-12-15
WO2005009428A3 (fr) 2005-04-07
US20060167100A1 (en) 2006-07-27
FR2857593A1 (fr) 2005-01-21
HRP20080521T3 (hr) 2009-01-31
WO2005009428A2 (fr) 2005-02-03
CA2532608A1 (fr) 2005-02-03
CN1819823A (zh) 2006-08-16
BRPI0412706A (pt) 2006-09-26
JP2006528160A (ja) 2006-12-14
KR100762598B1 (ko) 2007-10-04
NO20060803L (no) 2006-02-17
AU2004258713A1 (en) 2005-02-03
MXPA06000712A (es) 2006-04-11
DE602004016751D1 (de) 2008-11-06

Similar Documents

Publication Publication Date Title
ATE407663T1 (de) Azithromycin enthaltende pharmazeutische zusammensetzungen mit verringerten nebenwirkungen
DE60307677D1 (de) Dispergierbare pharmazeutische zusammensetzungen
FI20011478A0 (fi) Farmaseuttinen koostumus
PT1501534E (pt) Formulacoes farmaceuticas
NO20033384D0 (no) Farmasöytisk formulering
ATE307571T1 (de) Pharmazeutische formulierung enthaltend bicalutamid
DE60213592D1 (de) Flüssige pharmazeutische zusammensetzung
ATE371456T1 (de) Pharmazeutische zusammensetzung enthaltend ein androgen
DK1587478T3 (da) Farmaceutisk sammensætning
DE60312049D1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
DE602004016967D1 (de) Flüssige pharmazeutische palonosetronformulierungen
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
DE60210139D1 (de) Pharmazeutische zusammensetzungen enthaltend tegaserod
NO20035627D0 (no) Farmasöytisk formulering
IS7051A (is) Lyfjasamsetningar
ATE477814T1 (de) Stabile faktor-viii enthaltende pharmazeutische zusammensetzung
FI20022128L (fi) Farmaseuttinen koostumus
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
ATE409032T1 (de) Orodispersible pharmazeutische zusammensetzung einer antithrombotischen verbindung
DE10291905D2 (de) Pharmazeutische Zusammensetzung
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
NO20034952D0 (no) Farmasöytiske forbindelser
DE10107261B4 (de) Pharmazeutische Zusammensetzung
NO20044164L (no) Farmasoytiske sammensetninger
DE602004030921D1 (de) Pharmazeutische zusammensetzung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1646373

Country of ref document: EP

REN Ceased due to non-payment of the annual fee